CJC1295 + Ipamorelin

CJC-1295 + Ipamorelin is a peptide combination studied for its synergistic effects on growth hormone signaling pathways. CJC-1295 functions as a growth hormone–releasing hormone (GHRH) analog, while Ipamorelin acts as a ghrelin receptor agonist, together promoting pulsatile growth hormone release in research models. This combination is commonly investigated in studies examining endocrine regulation, IGF-1 signaling, and metabolic pathways associated with growth hormone activity. Researchers often explore its role in growth hormone dynamics, recovery signaling, and metabolic regulation. For Research Purposes Only.